These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 19691117

  • 1. Characterization of polymorph transformations that decrease the stability of tablets containing the WHO essential drug mebendazole.
    Brits M, Liebenberg W, de Villiers MM.
    J Pharm Sci; 2010 Mar; 99(3):1138-51. PubMed ID: 19691117
    [Abstract] [Full Text] [Related]

  • 2. Identification of the mebendazole polymorphic form present in raw materials and tablets available in South Africa.
    Liebenberg W, Dekker TG, Lötter AP, de Villiers MM.
    Drug Dev Ind Pharm; 1998 May; 24(5):485-8. PubMed ID: 9876612
    [Abstract] [Full Text] [Related]

  • 3. Mebendazole crystal forms in tablet formulations. An ATR-FTIR/chemometrics approach to polymorph assignment.
    Calvo NL, Kaufman TS, Maggio RM.
    J Pharm Biomed Anal; 2016 Apr 15; 122():157-65. PubMed ID: 26874854
    [Abstract] [Full Text] [Related]

  • 4. Intermolecular contacts influencing the conformational and geometric features of the pharmaceutically preferred mebendazole polymorph C.
    Martins FT, Neves PP, Ellena J, Camí GE, Brusau EV, Narda GE.
    J Pharm Sci; 2009 Jul 15; 98(7):2336-44. PubMed ID: 18855910
    [Abstract] [Full Text] [Related]

  • 5. Analysing the crystal purity of mebendazole raw material and its stability in a suspension formulation.
    Agatonovic-Kustrin S, Glass BD, Mangan M, Smithson J.
    Int J Pharm; 2008 Sep 01; 361(1-2):245-50. PubMed ID: 18555626
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Developing a discriminating dissolution test for three mebendazole polymorphs based on solubility differences.
    Swanepoel E, Liebenberg W, Devarakonda B, de Villiers MM.
    Pharmazie; 2003 Feb 01; 58(2):117-21. PubMed ID: 12641328
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Quantitative analysis and evaluation of solid-state stability of mebendazole Forms A and C suspensions by powder X-ray diffraction using the Rietveld method.
    Ticona Chambi J, Deris Prado L, Ferreira de Carvalho Patricio B, Ceballos M, Bianco I, Fandaruff C, Antunes Rocha HV, Kuznetsov A, Lucia Cuffini S.
    Int J Pharm; 2024 Jan 25; 650():123721. PubMed ID: 38110011
    [Abstract] [Full Text] [Related]

  • 11. Modeling of in-use stability for tablets and powders in bottles.
    Waterman KC, Chen L, Waterman P, MacDonald BC, Monahan AP, Scrivens G.
    Drug Dev Ind Pharm; 2016 Oct 25; 42(10):1571-8. PubMed ID: 27050806
    [Abstract] [Full Text] [Related]

  • 12. Characterization of solid-state forms of mebendazole.
    Kumar S, Chawla G, Sobhia ME, Bansal AK.
    Pharmazie; 2008 Feb 25; 63(2):136-43. PubMed ID: 18380400
    [Abstract] [Full Text] [Related]

  • 13. Quality evaluation of generic drugs by dissolution test: changing the USP dissolution medium to distinguish between active and non-active mebendazole polymorphs.
    Swanepoel E, Liebenberg W, de Villiers MM.
    Eur J Pharm Biopharm; 2003 May 25; 55(3):345-9. PubMed ID: 12754010
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anthelmintic efficacy of mebendazole depends on the molecular polymorph.
    Evans AC, Fincham JE, Dhansay MA, Liebenberg W.
    S Afr Med J; 1999 Nov 25; 89(11):1118. PubMed ID: 10599275
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.